Joint effects of C-reactive protein and other risk factors on acute coronary events

American Heart Journal

Volumn 141, Issue 4, 2001, Pages 580-585

  Kervinen, Helena ^a   Palosuo, Timo ^b   Manninen, Vesa ^c   Tenkanen, Leena ^c   Vaarala, Outi ^b   Mänttäri, Matti ^c  

^a HYVINKÄÄ HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; C REACTIVE PROTEIN; IMMUNOGLOBULIN G ANTIBODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTHROMBIN; PROTHROMBIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGRESSION ANALYSIS; RISK FACTOR;

EID: 0035091687     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.113572     Document Type: Article

References (27)

1. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
2. Detection of activated T lymphocytes in the human atherosclerotic plaque
3. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes
4. Mast cell infiltration in acute coronary syndromes: Implications for plaque rupture
5. Interleukin-6: The major regulator of acute phase protein synthesis in man and rat
6. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
7. C-reactive protein, a sensitive marker of inflammation predicts risk of coronary heart disease in initially healthy middle-aged men
8. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study
9. Inflammation, aspirin, and the cardiovascular disease in apparently healthy men
10. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
11. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
12. Infections, inflammation, and the risk of coronary heart disease
13. Antibody against oxidized low-density lipoprotein predicting myocardial infarction
14. Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men
15. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men
16. The Helsinki Heart Study: Coronary heart disease incidence during an extended follow-up
17. Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia
18. For the cholesterol and recurrent events (CARE) investigators: Long-term effects of pravastatin on plasma concentration of C-reactive protein
19. Effects of statins on C-reactive protein in patients with coronary artery disease
20. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study)
21. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
22. Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M
23. Serum ferritin and ceruloplasmin as coronary risk factors
24. Effect of strenuous exercise on fibrinogen and fibrinolysis in healthy elderly men and women
25. Lipoproteins and acute phase response during acute infection: Interrelationships between C-reactive protein and serum amyloid-A protein and lipoproteins
26. Lipid profiles in untreated patients with rheumatoid arthritis
27. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease